Please Wait

Applying Filters...

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

SENSORCAINE-1

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 4 USDMF, 5 CEP/COS, 2 JDMF, 2 EU WC, 2 KDMF, 12 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

157 FDF Dossiers, 31 FDA Orange Book, 94 Europe, 31 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML), INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Kirsch Pharma, 4 Actylis, 2 CD Formulation

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 4 Thickeners and Stabilizers, 1 Taste Masking

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

36 Regulatory FDF Prices

36 Regulatory FDF Prices

MARKET PLACE

28 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 2 JP, 1 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Transo-Pharm Handels GmbH	Germany	TRANSO-PHARM HANDELS GMBH Siek DE	R1-CEP 2016-233 - Rev 00	Adrenaline tartrate	2023-02-09	Valid	Chemical		254
29/11/2025	Cambrex Corporation	U.S.A	Cambrex Profarmaco Milano S.r.l. Paullo IT	R1-CEP 2013-221 - Rev 00	Adrenaline tartrate	2020-05-12	Valid	Chemical		254

Contact us
to update this info

SENSORCAINE-1

SENSORCAINE-1

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

4 USDMF

5 CEP/COS

2 JDMF

2 EU WC

2 KDMF

12 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

157 FDF Dossiers

31 FDA Orange Book

94 Europe

31 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.25%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Kirsch Pharma

4 Actylis

2 CD Formulation

EXCIPIENTS BY APPLICATIONS

8 Parenteral

4 Thickeners and Stabilizers

1 Taste Masking

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

36 Regulatory FDF Prices

MARKET PLACE

28 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM

2 JP

1 Others

Filters